PT1157688E - Formulacoes oftalmicas aquosas antibacterianas contendo ofloxacina e quitosano - Google Patents

Formulacoes oftalmicas aquosas antibacterianas contendo ofloxacina e quitosano

Info

Publication number
PT1157688E
PT1157688E PT00111377T PT00111377T PT1157688E PT 1157688 E PT1157688 E PT 1157688E PT 00111377 T PT00111377 T PT 00111377T PT 00111377 T PT00111377 T PT 00111377T PT 1157688 E PT1157688 E PT 1157688E
Authority
PT
Portugal
Prior art keywords
ofloxacin
ofthalmic
formulacs
analbacterial
quitosan
Prior art date
Application number
PT00111377T
Other languages
English (en)
Inventor
Robert Gurny
Olivia Mireille Felt
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Publication of PT1157688E publication Critical patent/PT1157688E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT00111377T 2000-05-26 2000-05-26 Formulacoes oftalmicas aquosas antibacterianas contendo ofloxacina e quitosano PT1157688E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00111377A EP1157688B1 (en) 2000-05-26 2000-05-26 Antibacterial aqueous ophthalmic formulations containing ofloxacin and chitosan

Publications (1)

Publication Number Publication Date
PT1157688E true PT1157688E (pt) 2003-08-29

Family

ID=8168851

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00111377T PT1157688E (pt) 2000-05-26 2000-05-26 Formulacoes oftalmicas aquosas antibacterianas contendo ofloxacina e quitosano

Country Status (11)

Country Link
US (1) US6589999B2 (pt)
EP (1) EP1157688B1 (pt)
AT (1) ATE238767T1 (pt)
BR (1) BR0102138B1 (pt)
CA (1) CA2346631C (pt)
CZ (1) CZ299195B6 (pt)
DE (1) DE60002448T2 (pt)
DK (1) DK1157688T3 (pt)
ES (1) ES2195819T3 (pt)
PL (1) PL201564B1 (pt)
PT (1) PT1157688E (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
US7125122B2 (en) * 2004-02-02 2006-10-24 Sharp Laboratories Of America, Inc. Projection system with corrective image transformation
WO2007002345A2 (en) * 2005-06-21 2007-01-04 Bausch & Lomb Incorporated Method for improving water solubility of chitosan
CN100350978C (zh) * 2005-07-12 2007-11-28 何伟 可载药的降解型泪道栓子及其制备方法
FR3016882A1 (fr) 2014-01-30 2015-07-31 Sofradim Production Procede de preparation de chitosane a haut degre d’acetylation
TWI713618B (zh) * 2015-10-29 2020-12-21 日商帝化製藥股份有限公司 外用劑
CN109846820B (zh) * 2019-04-09 2020-09-29 广东三蓝药业股份有限公司 一种氧氟沙星滴眼液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675535A5 (pt) * 1988-11-28 1990-10-15 Nestle Sa
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
EP1128809B1 (en) * 1998-11-20 2004-12-29 Laboratoire Medidom S.A. Aqueous ophthalmic formulations comprising chitosan

Also Published As

Publication number Publication date
EP1157688A1 (en) 2001-11-28
CZ299195B6 (cs) 2008-05-14
CZ20011784A3 (cs) 2002-02-13
BR0102138A (pt) 2002-03-12
US6589999B2 (en) 2003-07-08
CA2346631A1 (en) 2001-11-26
PL201564B1 (pl) 2009-04-30
PL347735A1 (en) 2001-12-03
DE60002448T2 (de) 2004-03-25
ES2195819T3 (es) 2003-12-16
ATE238767T1 (de) 2003-05-15
EP1157688B1 (en) 2003-05-02
BR0102138B1 (pt) 2013-03-19
CA2346631C (en) 2008-12-02
US20020002148A1 (en) 2002-01-03
DK1157688T3 (da) 2003-08-25
DE60002448D1 (de) 2003-06-05

Similar Documents

Publication Publication Date Title
WO2002051464A3 (en) Antimicrobial medical devices
DK1169392T3 (da) Vandbaserede polyamidamidsyresammensætninger
LV10688A (lv) Pretalergisks sastavs oftalmologijai vai deguna slimibam
CA2378424A1 (en) Moxifloxacin formulation containing common salt
CA2309172A1 (en) Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
HUP0302161A2 (hu) Vizes fertżtlenítż rendszerek
HRP20010878B1 (en) Ziprasidone suspension
GR3032116T3 (en) A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
PT1157688E (pt) Formulacoes oftalmicas aquosas antibacterianas contendo ofloxacina e quitosano
WO2003082926A3 (en) Antimicrobial polymer conjugates
AU2003294565A8 (en) Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
DK1128809T3 (da) Vandige oftalmiske formuleringer omfattende chitosan
BR0210632A (pt) Tratamento de doença parasìtica
SE0001916D0 (sv) Novel formulation
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
FR2821551B1 (fr) Utilisations de derives de polyaminoacides comme agents hydratants, et compositions cosmetiques ou pharmaceutiques les comprenant
WO2003030862A3 (en) Anaesthetic compositions and method for their administration
DE60034770D1 (de) Stabile fumagillin-formulierung
RU2001100069A (ru) Антгельминтное средство
WO2002002087A3 (de) Anthelmintika zur verhinderung von parasitären infektionen bei menschen und tieren ii
FR2805267B1 (fr) Biopolymere dispersable et a hydratation rapide
WO2002002115A3 (de) Anthelmintika zur verhinderung von parasitären infektionen bei mensch und tier
CA2468033A1 (en) A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent